| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 352.471 | 375.645 | 379.942 | 368.256 | 417.401 | 279.189 | 345.558 | 395.196 | 386.441 | 415.464 |
| Total Income - EUR | 680.259 | 591.068 | 375.619 | 366.648 | 463.964 | 250.290 | 391.842 | 360.876 | 352.721 | 418.879 |
| Total Expenses - EUR | 572.162 | 482.843 | 258.358 | 265.573 | 353.789 | 180.040 | 279.486 | 235.941 | 250.676 | 302.527 |
| Gross Profit/Loss - EUR | 108.097 | 108.225 | 117.261 | 101.075 | 110.175 | 70.250 | 112.356 | 124.935 | 102.044 | 116.351 |
| Net Profit/Loss - EUR | 90.251 | 93.661 | 112.847 | 96.407 | 106.001 | 67.639 | 109.327 | 121.830 | 99.405 | 104.102 |
| Employees | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Ambrosia Bioscience Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 198.926 | 3.922 | 48.282 | 31.853 | 17.365 | 3.685 | 3.704 | 3.512 | 6.109 | 28.392 |
| Current Assets | 510.749 | 266.058 | 252.753 | 240.043 | 262.791 | 227.915 | 267.320 | 332.520 | 322.971 | 306.362 |
| Inventories | 31.649 | 31.688 | 107.948 | 78.828 | 71.045 | 50.898 | 88.368 | 55.316 | 85.410 | 38.389 |
| Receivables | 164.432 | 165.414 | 68.720 | 60.673 | 174.584 | 62.828 | 70.697 | 225.458 | 151.473 | 219.536 |
| Cash | 314.669 | 68.955 | 76.085 | 100.542 | 17.162 | 114.190 | 108.255 | 51.746 | 86.088 | 48.437 |
| Shareholders Funds | 680.695 | 93.928 | 113.110 | 207.441 | 106.253 | 113.467 | 144.045 | 122.074 | 130.406 | 104.344 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 29.619 | 176.653 | 187.925 | 64.455 | 173.903 | 118.133 | 126.979 | 213.958 | 198.674 | 230.411 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2120 - 2120" | |||||||||
| CAEN Financial Year |
2120
|
|||||||||
Comments - Ambrosia Bioscience Srl